Virtual Сonferences 

The Emerging Longevity Industry - A UAE Perspective (1920x1080).png

Longevity is an emerging industry that is expanding with the speed of light, and the UAE is riding this wave of growth by exploring the Longevity industry. From longevity clinics to aging-friendly policies, the UAE is progressing on every tangent. 

"The Emerging Longevity Industry — A UAE Perspective" is an online event, where we discuss how the UAE is creating the future leaders to advance the Longevity agenda and many other things related to the Longevity industry. 

Save the date! February 2, 2022, 3 to 4 PM UAE Standard Time (GMT+4:00).

Facebook 1920x1080 (2).png

“The State of FemTech 2021-2022: Industry Review and Outlook” is a free virtual event combining speaker’s talks and the panel discussion on what to expect in women’s health and FemTech in 2022.


During the conference, each panelist will conduct a 10 minute talk followed by a joint panel discussion from the moderator and the audience.

Impact Investments (1920x1080).png

Deep Knowledge Group is pleased to host its free virtual event “Global Impact Investing: Success stories from across the world is confirmed”, which brings together industry leaders and influencers in the subject of impact investing. Our speakers will share valuable insights on their investing strategies and social activities with an emphasis on global impact.

In 2020, the market size of impact investing was USD 715 billion. It is projected to reach a size of USD 791.2 billion by 2027, growing at a CAGR of 17.6%.

AI main page.png

On behalf of Big Innovation Centre and Deep Knowledge Analytics, we would like to invite you to the official Press Launch of our major analysis and report, ‘AI Industry in the UK Landscape Overview 2021'.  It is a new version of our previous analysis and report published in dialogue with the All-Party Parliamentary Group on Artificial Intelligence (APPG AI) in 2018 which contained the first comprehensive mapping of the UK AI landscape. 

Landscape of Cancer Vaccines and Research Platforms (Facebook).png

Deep Pharma Intelligence held a virtual event (November 23), which was a unique opportunity share our findings from a unique market study revealing R&D platforms for developing therapeutic cancer vaccines, the key players in each category, the science behind the development, and case studies illustrating opportunities and challenges of each research strategy. 

We presented our categorization of the 5 platforms — including relatively mainstream strategies — Neoantigen Platform, Tumor-associated Antigens Platform, Cellular Platform, and Oncolytic Viruses Platform,  Antigenic Essence Platform. 

The Rise of Advanced Technologies in the Pharmaceutical Industry 1920x1080 (2)-min.png

Deep Pharma Intelligence is inviting you to participate in a 3-day virtual event (November 15-17), which is a unique opportunity to learn insights and case studies from two major proprietary analytical reports by the company: “Landscape of Advanced Technology Companies in the Pharmaceutical Industry”, and “AI for Drug Discovery, Biomarker Development, and Advanced R&D Landscape”.  

Biomarkers of Human Longevity Conference (1920х1080).webp

Biomarkers of Human Longevity: State of the Market and Diversity of Practical Applications Q4 2021 is an upcoming 2-day virtual conference featuring talks and panel discussions among industry leaders, companies, investors and practitioners in the rapidly growing domain of Biomarkers of Human Longevity.

The event is free-of-charge to attend, and will provide a stat-of-the-market overview and key company and investor take-aways for Q4 2021, highlighting key industry trends, challenges, opportunities and recent developments, and explore the rapidly growing diversity of market-ready, practical applications within the industry.

The Technology Revolution of FoodTech Industry 1920x1080 (3)-min.png

On "The Technology Revolution of FoodTech Industry" webinar influencers and main experts of the FoodTech industry will share their insights and researches of emerging trends and application of modern technologies in the industry. 

During this open-access event, global experts of the FoodTech industry will discuss new horizons of the market. The FoodTech Industry is developing rapidly and includes more than 5,000 startups globally.

The Future of Space Medicine (1920x1080).png

The Future of Space Medicine was carried out in an online format. Understanding of new technologies emerging for space medicine will become ever-more important with the soon-to-come plunging of launch prices, enabling thousands of people, many not necessarily in the best of physical health, to visit space in the near future. With that much activity, the chances of accidents will vastly increase, and many of them will need to be dealt with in space, because waiting for an ambulance to get back to Earth may be too late. 

GovTech Development During COVID-19 (1920x1080) 11 (2).webp

"GovTech Development During COVID-19: How Technologies Have Helped’ was a virtual conference dedicated to coverage of the most effective E-government and GovTech solutions, implemented during the COVID-19 period. 

The event brought together policy-makers, government officials and field experts all over the world to share their experiences and insights learnt from the pandemic.

Femtech Conference 1920x1080.webp

FemTech Advancing Women's Wellness and Lifespan was a virtual conference which had two panels, 13 speakers, over 220 registrants and 100+ attendees who are FemTech founders & CEOs, investors, physicians, scientists, influencers and other key players.

The event was focused on the impact of technologies on women’s health and lifespan and how FemTech contributes to women’s Longevity in general. 

Staying Healthy in Space (1920x1080) (1).png

Staying Healthy in Space was a virtual conference in which speakers from the space-medical community discussed the opportunities and challenges presented by the coming rapid growth in the number of humans working, playing, and perhaps even living in space – as a key part of expanding human presence in space and in generating economic benefit both off-planet and terrestrial, from space activities. Speakers addressed the issues, potential solutions to them, and identify areas of necessary research to better understand both the issues and best solutions.

Femtech Conference 1920x1080 (1)-min.webp

The virtual conference "FemTech Industry Landscape 2021: Discovering New Horizons" held on July 29, 2021, where professionals from FemTech Analytics and invited guest speakers who are Founders & CEO of FemTech companies and start-ups, Healthcare Innovators, Investors and Hubs, Women Influencers and Enthusiasts shared insights, findings and personal experience about new possibilities and cutting-edge technologies in fast developing FemTech market.

All Speakers Banner V2.png

“Longevity.International presents: Biomarkers Of Human Longevity” was a virtual 1-day conference that took place June 30, 2021 featuring presentations from a variety of companies, key players and thought-leaders active within the Biomarkers of Human Aging and Longevity Industry.

​The event explored the present state of the industry, as well as key strategic challenges and opportunities for translating the potentials of Biomarkers of Human Longevity from theory into practice.

Screenshot 2021-06-07 at 22.41.47.png

"Practical Applications of Mitochondria Research for Human Longevity and Space Medicine" was a virtual conference that took place June 9-10, 2021, where professionals from Aging Analytics Agency and guest speakers who are Practical Longevity Experts, Space Medicine Experts and Women Influencers shared insights, findings and personal experiences about the Role of Mitochondria in The Practical Human Longevity and Scientific Approaches to Women For Extending Reproductive Longevity.

Add a subheading (1).png

The newest computational approach to drug repositioning showing the greatest promise is AI and machine learning. With a drug-repurposing strategy, AI can quickly detect drugs that can fight against emerging diseases (such as Covid-19) as well as existing diseases.

The AI Driven Drug Repositioning & Repurposing Summit brought together 80+ leaders in repurposing and pioneers in A.

practical.png

Episode 1 of the new series Practical Human Longevity focused on market-ready technologies and approaches for Intermittent Hypoxia, Hyperoxia and their relation to Mitochondrial Aging and Healthy Human Longevity. Dmitry Kaminskiy and Arkadii Prokopov considered the pros and cons of different approaches within this general paradigm during their discussion. They showcased the tangible results on health and performance that Dmitry has experienced since beginning to integrate these technologies into his daily Personal Longevity Regime, followed by a keynote lecture on the tangible links between intermittent hypoxia and hyperoxia and human aging and Longevity.

AI-driven webinar (2).jpeg

Webinar held on April 13, 2021. Analysts from Deep Pharma Intelligence and guest speakers shared insights and findings about trends and application use cases of artificial intelligence (AI) in the pharmaceutical research, biotech, and healthcare tech, focused specifically on tackling the coronavirus pandemics.

The event featured a summary of key players, technologies and trends, including R&D and business aspects, as well as investment trends on the cross-roads of AI and COVID-19 therapeutics and tools.

0 (common) (1).png

Webinar held on March 3, 2021. It presented key findings and insights from Deep Pharma Intelligence AI in the Pharma Investment Digest.

​The event provided a summary of key players, trends in the private equity and venture capital ecosystem, with a focus on the growing maturity of the AI market in Pharma, and key takeaways for investors in 2021.

DPI AI in Pharma Webinar.png

Day 1 (Top AI in Pharma Deals, Trends & Partnerships 2020-Q1 2021) featured presentations and a roundtable discussion on the biggest deals, partnerships, collaborations, and industry events in the AI in Pharma sector from 2020 - 2021.

Day 2 (Investment and M&A Deals: AI in Pharma Market 2021) featured talks and a panel discussion on key players, trends in the private equity and venture capital ecosystem, focusing on the increasing market maturation of AI in Pharma, and key take-aways for investors in 2021.

0 (common) (2).png

Webinar held on March 2, 2021. It presented key findings and take-aways from Deep Pharma Intelligence's newest special analytical case study.
The event provided a discussion of the biggest deals, partnerships, collaborations, and industry events in the AI in Pharma sector from 2020-2021.

Add a subheading (2).png

The AI-ML: Drug Discovery Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform.

​Designed with leading AI experts from R&D and clinical departments across big pharma, biotech, and academia, this year’s forum features 3 days of real-world case studies and interactive discussions. As such, the 2021 AI-ML Summit will provide you with a roadmap to augmented R&D and clinical decision making with reduced failure rates, increased speed, and improved margins.

maxresdefault.jpeg

Deep Pharma Intelligence team introduced the company and its founding partners Deep Knowledge Analytics and BiopharmaTrend, and shared their insights and statistics about the Pharmaceutical Artificial Intelligence (AI) sector, including current trends, leaders in the “AI Race”, key R&D partnership and major investment deals, and latest industry developments. The company has paid particular attention to investment opportunities in this increasingly attractive market.

Add a subheading (4).png

The 3rd Annual AI-ML: Drug Discovery & Development Summit is the industry’s definitive guide to translating the wealth of tech available to successful, efficacious and efficient R&D processes. With 3 days of real-world case studies, this summit will provide the roadmap to augmented R&D decision making with reduced failure rates, increased speed and improved margins.

​This year’s summit will take a deeper look at:

  • Target, pathway and molecule selection – identifying which will treat individual disease indications better

  • Predictive preclinical models – knowing from the beginning how drug candidates will react when administered to in vivo and in vitro models

Add a subheading (3).png

Building on the success in 2019, the 2nd Longevity Therapeutics 2020 Summit will once again return to San Francisco. As the only industry-led and end-to-end longevity meeting, we will hear success stories in the last 12 months and explore what’s next to help you accelerate your pipeline into clinic! Uniting biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative anti-aging drugs and overcome key preclinical, translational, clinical and regulatory challenges going forward.

Add a subheading (5).png

Welcome to the AI Applications in Biopharma Summit; a new kind of collaborative experience where the industry’s top science minds, AI technology experts and strategy leaders share detailed use cases to help each other build out the adoption of AI technology to improve patients’ lives.

​The Summit is a ‘who’s who’ of AI in biopharma and is your chance to engage in deep coverage of AI in drug discovery, clinical development and real-world evidence from an elite speaker

longevity.png

The world’s first international, cross-border, cross-sector summit on International Longevity Policy and Governance as part of Longevity Forum’s Longevity Week 2019, bringing together world-leading policy experts, representatives of government bodies, departments, healthcare and finance ministries, executives of healthcare and financial corporations to discuss, network and collaborate on initiatives to promote international longevity development.

practical.png

Episode 1 of the new series Practical Human Longevity focused on market-ready technologies and approaches for Intermittent Hypoxia, Hyperoxia and their relation to Mitochondrial Aging and Healthy Human Longevity. Kaminskiy and Prokopov considered the pros and cons of different approaches within this general paradigm during their discussion. They showcased the tangible results on health and performance that Kaminskiy has experienced since beginning to integrate these technologies into his daily Personal Longevity Regime, followed by a keynote lecture on the tangible links between intermittent hypoxia and hyperoxia and human aging and Longevity.

AI2.png

The inaugural, exclusive and invitation-only AI for Longevity Summit, organized at King’s College London, brought together leading scientists, industry players, and experts to highlight the latest advances in Artificial Intelligence for Longevity and the practical implementation of longevity technologies and therapeutics. It was the first in a series of conferences, which we expect to become the world-leading forum on AI for Longevity. 

targ conf.png

Targeting Metabesity 2019 conference focused on the prevention of noncommunicable diseases and the treatment of age-related health dysfunctions to extend health-adjusted life expectancy. The conference, was held October 15-16, 2019 at the Carnegie Institution for Science in Washington, D.C., addressed one of the important issues in healthcare: the constellation of major chronic diseases, including diabetes, cardiovascular disease, dementia, cancer, and the aging process, that are considered to be the “slow motion disaster”. 

King's College Longevity Summits: AI, Policy, Finance

74495936_769795826766913_550314985129194

Press-Releases